PENZBERG, Germany--(BUSINESS WIRE)--Following the launch of the xCELLigence RTCA SP Instrument in June, Roche Applied Science has introduced the new xCELLigence RTCA MP Instrument. In comparison with the RTCA SP, the new RTCA MP Instrument has a higher throughput capacity and it is more versatile which enables application on a wider range of experimental set-ups. The new system features six E-Plates 96 as opposed to only one in the RTCA SP; this advantage increases the result output by factor six. Each E-Plate can be individually addressed in independent experiments enabling a larger group of researchers to work simultaneously. The new system will find its preferred use in the field of pharma research; the first systems have already been delivered to major pharmaceutical companies.
